|
GB699812A
(en)
|
1950-11-29 |
1953-11-18 |
British Ind Solvents Ltd |
Manufacture of substituted pyrimidones
|
|
GB1053063A
(sr)
|
1963-05-18 |
|
|
|
|
DE1670912C3
(de)
|
1967-08-18 |
1981-06-11 |
Bayer Ag, 5090 Leverkusen |
Herbizide Mittel auf Basis von 1,2,4-Triazin-5-onen
|
|
GB1377642A
(en)
|
1971-01-14 |
1974-12-18 |
Koninklijke Gist Spiritus |
Penicillanic and cephalosporanic acid derivatives
|
|
US3960949A
(en)
*
|
1971-04-02 |
1976-06-01 |
Schering Aktiengesellschaft |
1,2-Biguanides
|
|
DE2150686A1
(de)
|
1971-10-12 |
1973-04-19 |
Basf Ag |
6-amino-uracil-5-carbonsaeurethioamide
|
|
BE792206A
(sr)
|
1971-12-02 |
1973-06-01 |
Byk Gulden Lomberg Chem Fab |
|
|
AU5996573A
(en)
|
1972-09-11 |
1975-03-06 |
Commonwealth Scientific And Industrial Research Organisation |
Pyridinium salts
|
|
US3823135A
(en)
|
1972-12-26 |
1974-07-09 |
Shell Oil Co |
Pyrimidone herbicides
|
|
GB1464248A
(en)
|
1973-11-01 |
1977-02-09 |
Ici Ltd |
Substituted triazinediones their preparation and use as herbicides
|
|
DE2361551A1
(de)
|
1973-12-11 |
1975-06-19 |
Basf Ag |
Wasserloesliche azofarbstoffe
|
|
DE2500024A1
(de)
|
1975-01-02 |
1976-07-08 |
Basf Ag |
Wasserloesliche azofarbstoffe
|
|
JPS535180A
(en)
|
1976-07-01 |
1978-01-18 |
Sumitomo Chem Co Ltd |
Preparation of 3,4-dihydro-2 (1h) quinazoline derivatives
|
|
DE2720085A1
(de)
|
1977-05-05 |
1978-11-16 |
Hoechst Ag |
Pyrimido(6,1-a)isochinolin-2-on- derivate
|
|
US4494978A
(en)
*
|
1976-12-30 |
1985-01-22 |
Chevron Research Company |
Herbicidal N-(N'-hydrocarbyloxycarbamylalkyl)-2,6-dialkyl-alpha-haloacetanilides
|
|
CH657851A5
(de)
|
1983-06-28 |
1986-09-30 |
Ciba Geigy Ag |
Chromogene chinazolonverbindungen.
|
|
AR240698A1
(es)
*
|
1985-01-19 |
1990-09-28 |
Takeda Chemical Industries Ltd |
Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
|
|
US5614492A
(en)
*
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
DE3856378T2
(de)
*
|
1987-09-04 |
2000-05-11 |
Beecham Group Plc |
Substituierte Thiazolidindionderivate
|
|
US4935493A
(en)
*
|
1987-10-06 |
1990-06-19 |
E. I. Du Pont De Nemours And Company |
Protease inhibitors
|
|
WO1989010701A1
(en)
|
1988-05-05 |
1989-11-16 |
Basf Aktiengesellschaft |
Substances based on uracil-derivates for stimulating growth and reducing fat in animals
|
|
GB8900382D0
(en)
|
1989-01-09 |
1989-03-08 |
Janssen Pharmaceutica Nv |
2-aminopyrimidinone derivatives
|
|
US5433955A
(en)
|
1989-01-23 |
1995-07-18 |
Akzo N.V. |
Site specific in vivo activation of therapeutic drugs
|
|
IE63502B1
(en)
|
1989-04-21 |
1995-05-03 |
Zeneca Ltd |
Aminopyrimidine derivatives useful for treating cardiovascular disorders
|
|
ATE164852T1
(de)
|
1990-01-24 |
1998-04-15 |
Douglas I Buckley |
Glp-1-analoga verwendbar in der diabetesbehandlung
|
|
JPH05504969A
(ja)
|
1990-02-13 |
1993-07-29 |
メルク・エンド・カムパニー・インコーポレーテツド |
置換ベンジル要素を含有するアンギオテンシン２アンタゴニスト類
|
|
US5366862A
(en)
|
1990-02-14 |
1994-11-22 |
Receptor Laboratories, Inc. |
Method for generating and screening useful peptides
|
|
US5814460A
(en)
|
1990-02-14 |
1998-09-29 |
Diatide, Inc. |
Method for generating and screening useful peptides
|
|
CA2036304C
(en)
|
1990-02-15 |
2001-04-17 |
Takehiko Naka |
Pyrimidinedione derivatives, their production and use
|
|
US5462928A
(en)
|
1990-04-14 |
1995-10-31 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
DE4110019C2
(de)
|
1991-03-27 |
2000-04-13 |
Merck Patent Gmbh |
Imidazopyridine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
|
|
US5387512A
(en)
*
|
1991-06-07 |
1995-02-07 |
Merck & Co. Inc. |
Preparation of 3-[z-benzoxazol-2-yl)ethyl]-5-(1-hydroxyethyl)-6-methyl-2-(1H)-pyridinone by biotransformation
|
|
US6825169B1
(en)
|
1991-10-22 |
2004-11-30 |
Trustees Of Tufts College |
Inhibitors of dipeptidyl-aminopeptidase type IV
|
|
WO1993008259A2
(en)
|
1991-10-22 |
1993-04-29 |
New England Medical Center Hospitals, Inc. |
Inhibitors of dipeptidyl-aminopeptidase type iv
|
|
US5350752A
(en)
|
1991-12-16 |
1994-09-27 |
E. R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
|
DE4141788A1
(de)
|
1991-12-18 |
1993-06-24 |
Merck Patent Gmbh |
Imidazopyridine
|
|
TW229142B
(sr)
|
1992-04-15 |
1994-09-01 |
Nissan Detrochem Corp |
|
|
US5602102A
(en)
|
1992-05-29 |
1997-02-11 |
Board Of Regents, The Univ. Of Tx System |
Dipeptidyl peptidase-I inhibitors and uses thereof
|
|
DE4305602A1
(de)
|
1992-06-17 |
1993-12-23 |
Merck Patent Gmbh |
Imidazopyridine
|
|
AU4794393A
(en)
|
1992-07-31 |
1994-03-03 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Producing increased numbers of hematopoietic cells by administering inhibitors of dipeptidyl peptidase iv
|
|
EP0587377A3
(en)
|
1992-09-10 |
1994-09-21 |
Lilly Co Eli |
Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
|
|
IL106998A0
(en)
*
|
1992-09-17 |
1993-12-28 |
Univ Florida |
Brain-enhanced delivery of neuroactive peptides by sequential metabolism
|
|
US5811281A
(en)
|
1993-07-12 |
1998-09-22 |
Cornell Research Foundation, Inc. |
Immortalized intestinal epithelial cell lines
|
|
IL111785A0
(en)
*
|
1993-12-03 |
1995-01-24 |
Ferring Bv |
Dp-iv inhibitors and pharmaceutical compositions containing them
|
|
DE4341453A1
(de)
|
1993-12-06 |
1995-06-08 |
Merck Patent Gmbh |
Imidazopyridine
|
|
CA2184891C
(en)
|
1994-03-08 |
2000-09-26 |
Yasuhisa Kuroki |
Phosphonic diester derivative
|
|
US5580979A
(en)
|
1994-03-15 |
1996-12-03 |
Trustees Of Tufts University |
Phosphotyrosine peptidomimetics for inhibiting SH2 domain interactions
|
|
US5543396A
(en)
|
1994-04-28 |
1996-08-06 |
Georgia Tech Research Corp. |
Proline phosphonate derivatives
|
|
US6090786A
(en)
|
1994-06-10 |
2000-07-18 |
Fondatech Benelux N.V. |
Serine proteases, their activity and their synthetic inhibitors
|
|
ES2214502T3
(es)
|
1994-06-17 |
2004-09-16 |
La Trobe University |
Control biologico de insectos.
|
|
US5601986A
(en)
*
|
1994-07-14 |
1997-02-11 |
Amgen Inc. |
Assays and devices for the detection of extrahepatic biliary atresia
|
|
DE4432860A1
(de)
|
1994-09-15 |
1996-03-21 |
Merck Patent Gmbh |
Imidazopyridine
|
|
US5512549A
(en)
*
|
1994-10-18 |
1996-04-30 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptide analogs, compositions, and methods of use
|
|
EP0767170B1
(en)
|
1995-04-13 |
2002-10-23 |
Taiho Pharmaceutical Co., Ltd. |
Novel 4,6-diarylpyrimidine derivatives and salts thereof
|
|
US5614379A
(en)
*
|
1995-04-26 |
1997-03-25 |
Eli Lilly And Company |
Process for preparing anti-obesity protein
|
|
US6325989B1
(en)
|
1995-06-01 |
2001-12-04 |
Dana-Farber Cancer Institute, Inc. |
Form of dipeptidylpeptidase IV (CD26) found in human serum
|
|
US6265551B1
(en)
|
1995-06-01 |
2001-07-24 |
Dana-Farber Cancer Institute, Inc. |
Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereof
|
|
PT748800E
(pt)
|
1995-06-09 |
2001-10-30 |
Hoffmann La Roche |
Derivados de pirimidinadiona pirimidinatriona triazinadiona como antagonistas do receptor alfa-1-adrenergico
|
|
JPH0928376A
(ja)
|
1995-07-21 |
1997-02-04 |
Ajinomoto Co Inc |
新規ジペプチジルペプチダーゼｉｖとその製造方法
|
|
US20020006899A1
(en)
|
1998-10-06 |
2002-01-17 |
Pospisilik Andrew J. |
Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals
|
|
DE19616486C5
(de)
|
1996-04-25 |
2016-06-30 |
Royalty Pharma Collection Trust |
Verfahren zur Senkung des Blutglukosespiegels in Säugern
|
|
JPH09295977A
(ja)
|
1996-04-30 |
1997-11-18 |
Terumo Corp |
ピリドピリミジン誘導体及びそれを含有する医薬組成物
|
|
US5965532A
(en)
|
1996-06-28 |
1999-10-12 |
Trustees Of Tufts College |
Multivalent compounds for crosslinking receptors and uses thereof
|
|
BR9711098B1
(pt)
|
1996-07-01 |
2011-10-04 |
|
compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos e seu uso no tratamento de diabetes e doenças relacionadas.
|
|
US5885997A
(en)
*
|
1996-07-01 |
1999-03-23 |
Dr. Reddy's Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
|
|
US6006753A
(en)
|
1996-08-30 |
1999-12-28 |
Eli Lilly And Company |
Use of GLP-1 or analogs to abolish catabolic changes after surgery
|
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
|
AU4721897A
(en)
|
1996-10-25 |
1998-05-22 |
Tanabe Seiyaku Co., Ltd. |
Tetrahydroisoquinoline derivatives
|
|
TW492957B
(en)
|
1996-11-07 |
2002-07-01 |
Novartis Ag |
N-substituted 2-cyanopyrrolidnes
|
|
US6011155A
(en)
*
|
1996-11-07 |
2000-01-04 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
CZ9902016A3
(cs)
|
1996-12-05 |
1999-11-17 |
Amgen Inc. |
Substituované pyrimidinonové a pyridonové sloučeniny a způsoby jejich použití
|
|
GB9702701D0
(en)
|
1997-02-01 |
1997-04-02 |
Univ Newcastle Ventures Ltd |
Quinazolinone compounds
|
|
US20030060434A1
(en)
*
|
1997-02-18 |
2003-03-27 |
Loretta Nielsen |
Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
|
|
US6100234A
(en)
|
1997-05-07 |
2000-08-08 |
Tufts University |
Treatment of HIV
|
|
CN1227363C
(zh)
|
1997-05-16 |
2005-11-16 |
诺沃奇梅兹生物技术有限公司 |
具有脯氨酰二肽氨肽酶活性的多肽和编码该多肽的核酸
|
|
EP0897012A1
(en)
|
1997-07-05 |
1999-02-17 |
Societe Des Produits Nestle S.A. |
Cloning of the prolyl-dipeptidyl-peptidase from aspergillus oryzae
|
|
US6235493B1
(en)
*
|
1997-08-06 |
2001-05-22 |
The Regents Of The University Of California |
Amino acid substituted-cresyl violet, synthetic fluorogenic substrates for the analysis of agents in individual in vivo cells or tissue
|
|
IL125950A0
(en)
|
1997-09-05 |
1999-04-11 |
Pfizer Prod Inc |
Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
|
|
TR200000815T2
(tr)
|
1997-09-29 |
2000-12-21 |
Point Therapeutics Inc. |
In vitro hematopoietik hücrelerin stimulasyonu.
|
|
US6485955B1
(en)
|
1997-10-06 |
2002-11-26 |
The Trustees Of Tufts University |
Quiescent cell dipeptidyl peptidase: a novel cytoplasmic serine protease
|
|
WO1999017799A1
(en)
|
1997-10-06 |
1999-04-15 |
Trustees Of Tufts College Et Al. |
Cytoplasmic dipeptidylpeptidase iv from human t-cells
|
|
KR20010031056A
(ko)
|
1997-10-10 |
2001-04-16 |
시토비아 인크. |
신규 형광 리포터 분자 및 카스파제에 대한 분석을 비롯한이의 용도
|
|
US6342611B1
(en)
*
|
1997-10-10 |
2002-01-29 |
Cytovia, Inc. |
Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
|
|
WO1999025719A1
(fr)
*
|
1997-11-18 |
1999-05-27 |
Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai |
Substance physiologiquement active, la sulphostine, procede de fabrication et utilisation
|
|
FR2771004B1
(fr)
*
|
1997-11-19 |
2000-02-18 |
Inst Curie |
Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
|
|
WO1999028474A2
(en)
|
1997-12-01 |
1999-06-10 |
The Government Of The United States Of America, Represented By The Secretary Of Health And Human Services |
Chemokine variants and methods of use
|
|
US6380357B2
(en)
*
|
1997-12-16 |
2002-04-30 |
Eli Lilly And Company |
Glucagon-like peptide-1 crystals
|
|
NZ505066A
(en)
*
|
1997-12-16 |
2002-10-25 |
Novozymes As |
Polypeptides having aminopeptidase activity and nucleic acids encoding same
|
|
CA2819705C
(en)
|
1998-02-02 |
2014-07-08 |
Trustees Of Tufts College |
Method of regulating glucose metabolism, and reagents related thereto
|
|
US20020061839A1
(en)
*
|
1998-03-09 |
2002-05-23 |
Scharpe Simon Lodewijk |
Serine peptidase modulators
|
|
AU3034299A
(en)
|
1998-03-09 |
1999-09-27 |
Fondatech Benelux N.V. |
Serine peptidase modulators
|
|
WO1999047152A2
(en)
|
1998-03-20 |
1999-09-23 |
Sloan Kettering Institute For Cancer Research |
Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells
|
|
CA2333927A1
(en)
|
1998-04-01 |
1999-10-07 |
Dupont Pharmaceuticals Company |
Pyrimidines and triazines as integrin antagonists
|
|
AU738222B2
(en)
|
1998-04-08 |
2001-09-13 |
Novartis Ag |
N-pyridonyl herbicides
|
|
FR2777283B1
(fr)
|
1998-04-10 |
2000-11-24 |
Adir |
Nouveaux composes peptidiques analogues du glucagon-peptide- 1 (7-37), leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
DE19823831A1
(de)
|
1998-05-28 |
1999-12-02 |
Probiodrug Ges Fuer Arzneim |
Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
|
|
DE69905038T2
(de)
*
|
1998-06-05 |
2003-06-05 |
Point Therapeutics Inc |
Cyclische boroprolinverbindungen
|
|
DE19828114A1
(de)
|
1998-06-24 |
2000-01-27 |
Probiodrug Ges Fuer Arzneim |
Produgs instabiler Inhibitoren der Dipeptidyl Peptidase IV
|
|
DE19828113A1
(de)
|
1998-06-24 |
2000-01-05 |
Probiodrug Ges Fuer Arzneim |
Prodrugs von Inhibitoren der Dipeptidyl Peptidase IV
|
|
US6129911A
(en)
|
1998-07-10 |
2000-10-10 |
Rhode Island Hospital, A Lifespan Partner |
Liver stem cell
|
|
EP1306091A3
(en)
|
1998-07-31 |
2003-05-21 |
Novo Nordisk A/S |
Stimulation of beta cell proliferation
|
|
DE19834591A1
(de)
|
1998-07-31 |
2000-02-03 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Steigerung des Blutglukosespiegels in Säugern
|
|
US7056734B1
(en)
|
1998-08-10 |
2006-06-06 |
The United States Of America As Represented By The Department Of Health And Human Services, Nih |
Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof
|
|
AU5480199A
(en)
|
1998-08-21 |
2000-03-14 |
Point Therapeutics, Inc. |
Regulation of substrate activity
|
|
AU6044699A
(en)
|
1998-09-17 |
2000-04-03 |
Akesis Pharmaceuticals, Inc. |
Compositions and methods for treatment of glucose metabolism disorders
|
|
DE19845153A1
(de)
|
1998-10-01 |
2000-04-06 |
Merck Patent Gmbh |
Imidazo[4,5]-pyridin-4-on-derivate
|
|
US20030176357A1
(en)
|
1998-10-06 |
2003-09-18 |
Pospisilik Andrew J. |
Dipeptidyl peptidase IV inhibitors and their uses for lowering blood pressure levels
|
|
CO5150173A1
(es)
|
1998-12-10 |
2002-04-29 |
Novartis Ag |
Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
|
|
DE19900471A1
(de)
|
1999-01-08 |
2000-07-13 |
Merck Patent Gmbh |
Imidazo[4,5c]-pyridin-4-on-derivate
|
|
KR100787254B1
(ko)
|
1999-01-22 |
2007-12-20 |
기린 홀딩스 가부시키가이샤 |
퀴놀린유도체 및 퀴나졸린유도체
|
|
CA2360324C
(en)
|
1999-02-10 |
2016-03-29 |
Curis, Inc. |
Peptide yy (pyy) for inducing glucose responsiveness in pancreatic islets
|
|
AU3960400A
(en)
|
1999-03-05 |
2000-09-28 |
Molteni L. E C. Dei Fratelli Alitti Societa' Di Esercizio S.P.A. |
Use of metformin in the preparation of pharmaceutical compositions capable of inhibiting the enzyme dipeptidyl peptidase iv
|
|
GB9906715D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for promoting growth
|
|
GB9906714D0
(en)
|
1999-03-23 |
1999-05-19 |
Ferring Bv |
Compositions for improving fertility
|
|
AU4031500A
(en)
|
1999-03-26 |
2000-10-16 |
Akesis Pharmaceuticals, Inc. |
Edible solids for treatment of glucose metabolism disorders
|
|
US6548529B1
(en)
|
1999-04-05 |
2003-04-15 |
Bristol-Myers Squibb Company |
Heterocyclic containing biphenyl aP2 inhibitors and method
|
|
JP2002542246A
(ja)
|
1999-04-20 |
2002-12-10 |
ノボ ノルディスク アクティーゼルスカブ |
新規な化合物、それらの製造及び使用
|
|
WO2000069911A1
(en)
*
|
1999-05-17 |
2000-11-23 |
Conjuchem, Inc. |
Long lasting insulinotropic peptides
|
|
DE19926233C1
(de)
|
1999-06-10 |
2000-10-19 |
Probiodrug Ges Fuer Arzneim |
Verfahren zur Herstellung von Thiazolidin
|
|
US6107317A
(en)
|
1999-06-24 |
2000-08-22 |
Novartis Ag |
N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US6172081B1
(en)
*
|
1999-06-24 |
2001-01-09 |
Novartis Ag |
Tetrahydroisoquinoline 3-carboxamide derivatives
|
|
US6110949A
(en)
|
1999-06-24 |
2000-08-29 |
Novartis Ag |
N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
US6528486B1
(en)
*
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
US6617340B1
(en)
|
1999-07-29 |
2003-09-09 |
Novartis Ag |
N-(substituted glycyl)-pyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
DE19940130A1
(de)
|
1999-08-24 |
2001-03-01 |
Probiodrug Ges Fuer Arzneim |
Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung
|
|
JP4748908B2
(ja)
|
1999-09-10 |
2011-08-17 |
ザ・ユニバーシティ・オブ・シドニー |
ジペプチジルペプチダーゼ
|
|
US6559188B1
(en)
*
|
1999-09-17 |
2003-05-06 |
Novartis Ag |
Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
|
|
US6414002B1
(en)
*
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
|
EP1216233A1
(en)
|
1999-09-28 |
2002-06-26 |
MERCK PATENT GmbH |
Quinazolinones
|
|
US6251391B1
(en)
*
|
1999-10-01 |
2001-06-26 |
Klaire Laboratories, Inc. |
Compositions containing dipepitidyl peptidase IV and tyrosinase or phenylalaninase for reducing opioid-related symptons
|
|
US6447772B1
(en)
|
1999-10-01 |
2002-09-10 |
Klaire Laboratories, Inc. |
Compositions and methods relating to reduction of symptoms of autism
|
|
AU7559900A
(en)
|
1999-10-08 |
2001-04-23 |
Meiji Seika Kaisha Ltd. |
M-substituted benzoic acid derivatives exhibiting integrinalphavbeta3 antagonism
|
|
US6261794B1
(en)
|
1999-10-14 |
2001-07-17 |
Saint Louis University |
Methods for identifying inhibitors of methionine aminopeptidases
|
|
US7230000B1
(en)
|
1999-10-27 |
2007-06-12 |
Cytokinetics, Incorporated |
Methods and compositions utilizing quinazolinones
|
|
WO2001034594A1
(en)
|
1999-11-12 |
2001-05-17 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
|
|
US20040152745A1
(en)
|
1999-11-12 |
2004-08-05 |
Guilford Pharmaceuticals, Inc. |
Dipeptidyl peptidase IV inhibitors and methods of making and using dipeptidyl peptidase IV inhibitors
|
|
GB9928330D0
(en)
|
1999-11-30 |
2000-01-26 |
Ferring Bv |
Novel antidiabetic agents
|
|
WO2001041779A2
(en)
*
|
1999-12-08 |
2001-06-14 |
1149336 Ontario Inc. |
Combined use of glp-2 receptor agonist and chemotherapeutic agent in treatment
|
|
US6380398B2
(en)
|
2000-01-04 |
2002-04-30 |
Novo Nordisk A/S |
Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
EP1741447B1
(en)
|
2000-01-21 |
2013-09-18 |
Novartis AG |
Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents
|
|
EP1254113A1
(en)
|
2000-01-24 |
2002-11-06 |
Novo Nordisk A/S |
N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
|
|
ES2383954T3
(es)
|
2000-01-25 |
2012-06-27 |
Neurocrine Biosciences, Inc |
Antagonistas del receptor de la hormona liberadora de ganodotropina y métodos relacionados con ellos
|
|
JP2003523366A
(ja)
*
|
2000-01-27 |
2003-08-05 |
イーライ・リリー・アンド・カンパニー |
グルカゴン様ペプチド１化合物の可溶化方法
|
|
US6569901B2
(en)
|
2000-01-28 |
2003-05-27 |
Novo Nordisk A/S |
Alkynyl-substituted propionic acid derivatives, their preparation and use
|
|
US7217722B2
(en)
|
2000-02-01 |
2007-05-15 |
Kirin Beer Kabushiki Kaisha |
Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
|
|
AU2001233622A1
(en)
|
2000-02-25 |
2001-09-03 |
Novo-Nordisk A/S |
Inhibition of beta cell degeneration
|
|
US6448045B1
(en)
|
2000-03-10 |
2002-09-10 |
The Regents Of The University Of California |
Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1
|
|
US6395767B2
(en)
*
|
2000-03-10 |
2002-05-28 |
Bristol-Myers Squibb Company |
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
|
|
US6608038B2
(en)
|
2000-03-15 |
2003-08-19 |
Novartis Ag |
Methods and compositions for treatment of diabetes and related conditions via gene therapy
|
|
EP1136482A1
(en)
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors
|
|
US6555519B2
(en)
*
|
2000-03-30 |
2003-04-29 |
Bristol-Myers Squibb Company |
O-glucosylated benzamide SGLT2 inhibitors and method
|
|
DK2055302T3
(da)
*
|
2000-03-31 |
2014-10-27 |
Royalty Pharma Collection Trust |
Fremgangsmåde til forbedring af signalering af øceller ved diabetes mellitus og til forebyggelse deraf
|
|
US6573096B1
(en)
|
2000-04-01 |
2003-06-03 |
The Research Foundation At State University Of New York |
Compositions and methods for inhibition of cancer invasion and angiogenesis
|
|
US6545170B2
(en)
*
|
2000-04-13 |
2003-04-08 |
Pharmacia Corporation |
2-amino-5, 6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
|
|
US20030105118A1
(en)
|
2000-04-18 |
2003-06-05 |
Shuji Masumoto |
Tricyclic quinazolinediones
|
|
PT1939203E
(pt)
|
2000-04-25 |
2015-02-04 |
Icos Corp |
Inibidores da isoforma delta da fosfatidil-inositol 3-quinase humana
|
|
GB0010188D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
GB0010183D0
(en)
|
2000-04-26 |
2000-06-14 |
Ferring Bv |
Inhibitors of dipeptidyl peptidase IV
|
|
DE10025464A1
(de)
|
2000-05-23 |
2001-12-06 |
Inst Medizintechnologie Magdeb |
Kombinierte Verwendung von Enzyminhibitoren zur Therapie von Autoimmunerkrankungen, bei Transplantationen und Tumorerkrankungen sowie Kombinationen von Enzyminhibitoren umfassende pharmazeutische Zubereitungen
|
|
US6783757B2
(en)
*
|
2000-06-01 |
2004-08-31 |
Kirkman Group, Inc. |
Composition and method for increasing exorphin catabolism to treat autism
|
|
WO2001094597A1
(en)
|
2000-06-09 |
2001-12-13 |
Prozymex A/S |
Purified proenzyme of dipeptidyl peptidase i (pro-dppi)
|
|
US6432969B1
(en)
|
2000-06-13 |
2002-08-13 |
Novartis Ag |
N-(substituted glycyl)-2 cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
|
|
TW583185B
(en)
|
2000-06-13 |
2004-04-11 |
Novartis Ag |
N-(substituted glycyl)-2-cyanopyrrolidines and pharmaceutical composition for inhibiting dipeptidyl peptidase-IV (DPP-IV) or for the prevention or treatment of diseases or conditions associated with elevated levels of DPP-IV comprising the same
|
|
US6627636B2
(en)
|
2000-06-15 |
2003-09-30 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
US6620821B2
(en)
|
2000-06-15 |
2003-09-16 |
Bristol-Myers Squibb Company |
HMG-CoA reductase inhibitors and method
|
|
US7078397B2
(en)
|
2000-06-19 |
2006-07-18 |
Smithkline Beecham Corporation |
Combinations of dipeptidyl peptidase IV inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
|
|
GB0014969D0
(en)
|
2000-06-19 |
2000-08-09 |
Smithkline Beecham Plc |
Novel method of treatment
|
|
EP1301187B1
(en)
|
2000-07-04 |
2005-07-06 |
Novo Nordisk A/S |
Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv)
|
|
AU2001269123A1
(en)
|
2000-07-10 |
2002-01-21 |
Bayer Aktiengesellschaft |
Regulation of human dipeptidyl-peptidase iv-like enzyme
|
|
TW535080B
(en)
|
2000-07-24 |
2003-06-01 |
Ten Square Co Ltd |
Method and apparatus for optimal fitting activities into customer idle time
|
|
JP2002042960A
(ja)
*
|
2000-07-25 |
2002-02-08 |
Yazaki Corp |
コネクタ支持機構
|
|
EA005817B1
(ru)
|
2000-08-01 |
2005-06-30 |
Фармасиа Корпорейшн |
Производные гексагидро-7-1h-азепин-2-илгексановой (или гексеновой) кислоты в качестве ингибиторов индуцибельной синтазы оксида азота
|
|
DE60135854D1
(de)
|
2000-08-04 |
2008-10-30 |
Warner Lambert Co |
2-(4-Pyridyl)amino-6-dialkoxyphenyl-pyrido(2,3-d)pyrimidin-7-one
|
|
BRPI0113146B8
(pt)
|
2000-08-10 |
2021-05-25 |
Mitsubishi Pharma Corp |
"derivados de prolina e composição farmacêutica que os compreende".
|
|
US20020165237A1
(en)
|
2000-08-11 |
2002-11-07 |
Fryburg David Albert |
Treatment of the insulin resistance syndrome
|
|
US20020037829A1
(en)
|
2000-08-23 |
2002-03-28 |
Aronson Peter S. |
Use of DPPIV inhibitors as diuretic and anti-hypertensive agents
|
|
US6900226B2
(en)
|
2000-09-06 |
2005-05-31 |
Hoffman-La Roche Inc. |
Neuropeptide Y antagonists
|
|
WO2002020804A1
(en)
|
2000-09-08 |
2002-03-14 |
Prozymex A/S |
Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses
|
|
US20020064736A1
(en)
|
2000-09-27 |
2002-05-30 |
Fuji Photo Film Co., Ltd. |
Dye-forming coupler, silver halide photographic light-sensitive material, and method for producing an azomethine dye
|
|
AU2001292874B2
(en)
|
2000-09-27 |
2006-06-15 |
Merck & Co., Inc. |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
|
SE0003599D0
(sv)
|
2000-10-05 |
2000-10-05 |
Thomas Johansson |
Anordning för fuktabsorption
|
|
EP1325910B1
(en)
*
|
2000-10-06 |
2008-09-17 |
Mitsubishi Tanabe Pharma Corporation |
Aliphatic nitrogenous five-membered ring compounds
|
|
AU1313802A
(en)
|
2000-10-12 |
2002-04-22 |
Ferring Bv |
Novel serine protease genes related to dppiv
|
|
AUPR107800A0
(en)
*
|
2000-10-27 |
2000-11-23 |
University Of Sydney, The |
Peptide and nucleic acid molecule ii
|
|
CN1471392A
(zh)
|
2000-10-27 |
2004-01-28 |
ǰ������ҩ��ɷ�����˾ |
用于治疗神经性及神经心理性疾患的方法
|
|
RU2003112618A
(ru)
*
|
2000-10-30 |
2004-09-27 |
Орто-Макнейл Фармасьютикал, Инк. (Us) |
Комбинированная терапия, включающая антидиабетические и противосудорожные средства
|
|
US6586198B2
(en)
|
2000-10-31 |
2003-07-01 |
Vanderbilt University |
Method of identifying susceptibility to angiotensin converting enzyme inhibto- and vasopeptidase-inhibitor-associated angioedema
|
|
EP1347755A2
(en)
|
2000-10-31 |
2003-10-01 |
Merck & Co., Inc. |
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
|
|
WO2002038742A2
(en)
|
2000-11-08 |
2002-05-16 |
The University Of Georgia Research Foundation, Inc. |
Dipeptidylpeptidases and methods of use
|
|
TWI243162B
(en)
|
2000-11-10 |
2005-11-11 |
Taisho Pharmaceutical Co Ltd |
Cyanopyrrolidine derivatives
|
|
US20020155565A1
(en)
|
2000-11-10 |
2002-10-24 |
Pilar Garin-Chesa |
FAP-activated anti-tumor compounds
|
|
US20030055052A1
(en)
*
|
2000-11-10 |
2003-03-20 |
Stefan Peters |
FAP-activated anti-tumor compounds
|
|
US20030203946A1
(en)
|
2000-11-17 |
2003-10-30 |
Carsten Behrens |
Glucagon antagonists/inverse agonists
|
|
HUP0500543A2
(hu)
*
|
2000-11-20 |
2005-09-28 |
Bristol-Myers Squibb Company |
Piridonszármazékok mint aP2 inhibitorok és a vegyületeket tartalmazó gyógyszerkészítmények
|
|
EA007538B1
(ru)
|
2000-12-11 |
2006-10-27 |
Туларик Инк. |
Антагонисты cxcr3
|
|
JPWO2002051836A1
(ja)
|
2000-12-27 |
2004-04-22 |
協和醗酵工業株式会社 |
ジペプチジルペプチダーゼ−ｉｖ阻害剤
|
|
DE10100053A1
(de)
|
2001-01-02 |
2002-08-22 |
Keyneurotek Ag I G |
Verwendung von Enzyminhibitoren der Dipeptidylpeptidase IV sowie der Aminopeptidase N und pharmazeutischen Zubereitungen daraus zur Prävention und/oder Therapie Ischämie-bedingter akuter und chronischer neurodegenerativer Prozesse und Erkrankungen
|
|
CA2627862C
(en)
|
2001-01-02 |
2009-12-22 |
Imtm Gmbh |
Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn)
|
|
WO2002059301A1
(en)
|
2001-01-27 |
2002-08-01 |
K.U. Leuven Research And Development |
Chemokines
|
|
MXPA03006918A
(es)
|
2001-02-02 |
2004-05-24 |
Takeda Chemical Industries Ltd |
Compuestos heterociclicos fusionados.
|
|
TWI255817B
(en)
|
2001-02-14 |
2006-06-01 |
Kissei Pharmaceutical |
Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof
|
|
WO2002066627A1
(en)
|
2001-02-16 |
2002-08-29 |
Bayer Aktiengesellschaft |
Regulation of human dipeptidyl peptidase 8
|
|
HU230382B1
(hu)
*
|
2001-02-24 |
2016-03-29 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xantinszármazékok, előállításuk és alkalmazásuk gyógyszerként
|
|
US6337069B1
(en)
*
|
2001-02-28 |
2002-01-08 |
B.M.R.A. Corporation B.V. |
Method of treating rhinitis or sinusitis by intranasally administering a peptidase
|
|
JP4178816B2
(ja)
|
2001-03-15 |
2008-11-12 |
田辺三菱製薬株式会社 |
医薬組成物
|
|
DE60229922D1
(de)
*
|
2001-03-19 |
2009-01-02 |
Novartis Ag |
Kombinationen, ein antidiarrhoikum und epothilon oder ein epothilonderivat enthaltend
|
|
WO2002076450A1
(en)
|
2001-03-27 |
2002-10-03 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
FR2822826B1
(fr)
*
|
2001-03-28 |
2003-05-09 |
Servier Lab |
Nouveaux derives sulfonyles d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
DE10115921A1
(de)
|
2001-03-30 |
2002-10-02 |
Boehringer Ingelheim Pharma |
Verfahren zur Herstellung von 4,6-Diaminopyrimido[5,4-d]pyrimidinen
|
|
US6890905B2
(en)
|
2001-04-02 |
2005-05-10 |
Prosidion Limited |
Methods for improving islet signaling in diabetes mellitus and for its prevention
|
|
GB0109146D0
(en)
|
2001-04-11 |
2001-05-30 |
Ferring Bv |
Treatment of type 2 diabetes
|
|
US6573287B2
(en)
|
2001-04-12 |
2003-06-03 |
Bristo-Myers Squibb Company |
2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
|
|
PE20021080A1
(es)
|
2001-04-12 |
2003-02-12 |
Boehringer Ingelheim Int |
Un anticuerpo especifico fapo bibh1 en el tratamiento del cancer
|
|
CN101172158A
(zh)
|
2001-05-11 |
2008-05-07 |
得克萨斯州立大学董事会 |
抗cd26单克隆抗体作为对与表达cd26的细胞相关疾病的治疗
|
|
FR2824825B1
(fr)
*
|
2001-05-15 |
2005-05-06 |
Servier Lab |
Nouveaux derives d'alpha-amino-acides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US20030060494A1
(en)
|
2001-05-18 |
2003-03-27 |
Nobuyuki Yasuda |
Pharmaceutical use of N-carbamoylazole derivatives
|
|
IL143366A0
(en)
|
2001-05-24 |
2002-04-21 |
Harasit Medical Res Services & |
Treatment of renal fibrosis
|
|
US7105556B2
(en)
*
|
2001-05-30 |
2006-09-12 |
Bristol-Myers Squibb Company |
Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
|
|
US6794379B2
(en)
*
|
2001-06-06 |
2004-09-21 |
Tularik Inc. |
CXCR3 antagonists
|
|
DE60209348T2
(de)
|
2001-06-20 |
2006-10-12 |
Merck & Co., Inc. |
Dipeptidylpeptidase-hemmer zur behandlung von diabetes
|
|
AU2002344820B2
(en)
|
2001-06-20 |
2006-12-14 |
Merck & Co., Inc. |
Dipeptidyl peptidase inhibitors for the treatment of diabetes
|
|
GB0115517D0
(en)
|
2001-06-25 |
2001-08-15 |
Ferring Bv |
Novel antidiabetic agents
|
|
KR20040015298A
(ko)
|
2001-06-27 |
2004-02-18 |
스미스클라인 비참 코포레이션 |
디펩티딜 펩티다제 억제제로서의 플루오로피롤리딘
|
|
DE10150203A1
(de)
|
2001-10-12 |
2003-04-17 |
Probiodrug Ag |
Peptidylketone als Inhibitoren der DPIV
|
|
US20030130199A1
(en)
|
2001-06-27 |
2003-07-10 |
Von Hoersten Stephan |
Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
|
|
US20030135023A1
(en)
|
2001-06-27 |
2003-07-17 |
Hans-Ulrich Demuth |
Peptide structures useful for competitive modulation of dipeptidyl peptidase IV catalysis
|
|
US7183290B2
(en)
|
2001-06-27 |
2007-02-27 |
Smithkline Beecham Corporation |
Fluoropyrrolidines as dipeptidyl peptidase inhibitors
|
|
WO2003002595A2
(en)
|
2001-06-27 |
2003-01-09 |
Probiodrug Ag |
Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
|
|
DE10154689A1
(de)
|
2001-11-09 |
2003-05-22 |
Probiodrug Ag |
Substituierte Aminoketonverbindungen
|
|
JP4300108B2
(ja)
|
2001-06-27 |
2009-07-22 |
スミスクライン ビーチャム コーポレーション |
ジペプチジルペプチダーゼ阻害剤としてのピロリジン類
|
|
US7368421B2
(en)
|
2001-06-27 |
2008-05-06 |
Probiodrug Ag |
Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis
|
|
US6869947B2
(en)
|
2001-07-03 |
2005-03-22 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
|
|
DE60225556D1
(de)
|
2001-07-03 |
2008-04-24 |
Novo Nordisk As |
Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
|
|
UA74912C2
(en)
|
2001-07-06 |
2006-02-15 |
Merck & Co Inc |
Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
|
|
AU2002322585A1
(en)
|
2001-07-20 |
2003-03-03 |
Adipogenix, Inc. |
Fat accumulation-modulating compounds
|
|
TW569108B
(en)
*
|
2001-07-24 |
2004-01-01 |
United Microelectronics Corp |
Method of combining power lines to form standard logic unit database
|
|
AU2002330672A1
(en)
|
2001-07-25 |
2003-02-17 |
Genset S.A. |
Gmg-1 polynucleotides and polypeptides and uses thereof
|
|
IL159872A0
(en)
|
2001-07-26 |
2004-06-20 |
Genset Sa |
Gmg-2 polypeptides and their use
|
|
JP2004536152A
(ja)
|
2001-07-30 |
2004-12-02 |
ノボ ノルディスク アクティーゼルスカブ |
新規ビニルｎ−（２−ベンゾイルフェニル）−ｌ−チロシン誘導体及び抗糖尿病剤等へのそれらの使用
|
|
CN1537093A
(zh)
|
2001-07-30 |
2004-10-13 |
ŵ��Ų�ڿ˹�˾ |
新乙烯基羧酸衍生物以及它们作为抗糖尿病等药物的用途
|
|
AU2002317599B2
(en)
|
2001-07-31 |
2008-04-03 |
The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
GLP-1 exendin-4 peptide analogs and uses thereof
|
|
JP2005509409A
(ja)
|
2001-08-08 |
2005-04-14 |
ジェンザイム・コーポレーション |
糖尿病および他の血糖疾患の治療方法
|
|
EP1285922A1
(en)
|
2001-08-13 |
2003-02-26 |
Warner-Lambert Company |
1-Alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors
|
|
JP2005508891A
(ja)
|
2001-08-13 |
2005-04-07 |
プロバイオドラッグ アーゲー |
レグマインの不可逆性システインプロテアーゼ阻害剤
|
|
JP2003128551A
(ja)
|
2001-08-15 |
2003-05-08 |
Sankyo Co Ltd |
新規抗糖尿病医薬組成物
|
|
US6844316B2
(en)
|
2001-09-06 |
2005-01-18 |
Probiodrug Ag |
Inhibitors of dipeptidyl peptidase I
|
|
DE10143840A1
(de)
|
2001-09-06 |
2003-03-27 |
Probiodrug Ag |
Neue Inhibitoren der Dipeptidylpeptidase I
|
|
US20030186963A1
(en)
|
2001-09-14 |
2003-10-02 |
Dorwald Florencio Zaragoza |
Substituted piperidines
|
|
KR20040033048A
(ko)
|
2001-09-14 |
2004-04-17 |
미츠비시 웰파마 가부시키가이샤 |
티아졸리딘 유도체 및 이의 약학적 용도
|
|
US6673829B2
(en)
*
|
2001-09-14 |
2004-01-06 |
Novo Nordisk A/S |
Aminoazetidine,-pyrrolidine and -piperidine derivatives
|
|
AU2002331311A1
(en)
|
2001-09-19 |
2003-04-01 |
Novo Nordisk A/S |
Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
|
|
ATE439360T1
(de)
|
2001-09-21 |
2009-08-15 |
Bristol Myers Squibb Co |
Lactamhaltige verbindungen und ihre derivate als faktor-xa-hemmer
|
|
KR100754596B1
(ko)
|
2001-09-21 |
2007-09-05 |
미쯔비시 웰 파마 가부시키가이샤 |
3-치환-4-피리미돈 유도체
|
|
CA2460121C
(en)
|
2001-09-21 |
2010-11-02 |
Mitsubishi Pharma Corporation |
3-substituted-4-pyrimidone derivatives
|
|
US7019010B2
(en)
|
2001-09-27 |
2006-03-28 |
Novertis Ag |
Combinations
|
|
HUP0402338A3
(en)
*
|
2001-10-01 |
2008-10-28 |
Bristol Myers Squibb Co |
Spiro-hydantoin compounds, their use as anti-inflammatory agents, pharmaceutical compositions containing them and intermediates for preparing them
|
|
WO2003030946A1
(en)
|
2001-10-09 |
2003-04-17 |
Novartis Ag |
Regulation of insulin production
|
|
US7064135B2
(en)
|
2001-10-12 |
2006-06-20 |
Novo Nordisk Inc. |
Substituted piperidines
|
|
PL377687A1
(pl)
|
2001-10-18 |
2006-02-06 |
Bristol-Myers Squibb Company |
Środki naśladujące ludzki peptyd glukagonopodobny typu 1 i ich zastosowanie w leczeniu cukrzycy i stanów związanych z cukrzycą
|
|
TWI301834B
(en)
|
2001-10-22 |
2008-10-11 |
Eisai R&D Man Co Ltd |
Pyrimidone compound and pharmaceutical composition including the same
|
|
GB0125445D0
(en)
*
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Protease Inhibitors
|
|
GB0125446D0
(en)
|
2001-10-23 |
2001-12-12 |
Ferring Bv |
Novel anti-diabetic agents
|
|
US6861440B2
(en)
*
|
2001-10-26 |
2005-03-01 |
Hoffmann-La Roche Inc. |
DPP IV inhibitors
|
|
BR0213958A
(pt)
|
2001-10-31 |
2004-09-08 |
Novartis Ag |
Métodos para tratar diabete e condições relacionadas com base em polimorfismos no gene tcf1
|
|
EP1442028A4
(en)
*
|
2001-11-06 |
2009-11-04 |
Bristol Myers Squibb Co |
SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
|
|
US20030125304A1
(en)
|
2001-11-09 |
2003-07-03 |
Hans-Ulrich Demuth |
Substituted amino ketone compounds
|
|
US20030089935A1
(en)
*
|
2001-11-13 |
2003-05-15 |
Macronix International Co., Ltd. |
Non-volatile semiconductor memory device with multi-layer gate insulating structure
|
|
AU2002360453C1
(en)
|
2001-11-26 |
2009-06-18 |
The Brigham And Women's Hospital, Inc. |
Methods for treating autoimmune disorders, and reagents related thereto
|
|
CA2467857C
(en)
|
2001-11-26 |
2010-08-24 |
Duane A. Burnett |
Piperidine-based mch antagonists for treatment of obesity and cns disorders
|
|
CA2468192A1
(en)
|
2001-11-26 |
2003-06-05 |
Trustees Of Tufts College |
Peptidomimetic inhibitors of post-proline cleaving enzymes
|
|
AU2002350217A1
(en)
|
2001-12-04 |
2003-06-17 |
Bristol-Myers Squibb Company |
Glycinamides as factor xa inhibitors
|
|
US7067517B2
(en)
|
2001-12-14 |
2006-06-27 |
Nero Nordisk A/S |
Use of compounds for decreasing activity of hormone-sensitive lipase
|
|
GB0129988D0
(en)
|
2001-12-14 |
2002-02-06 |
Ferring Bv |
Imidazolidineacetic acid derivatives
|
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
KR101018318B1
(ko)
|
2001-12-21 |
2011-03-04 |
노보 노르디스크 에이/에스 |
Ｇｋ 활성제로서의 아미드 유도체
|
|
AU2002360732A1
(en)
|
2001-12-26 |
2003-07-24 |
Guilford Pharmaceuticals |
Change inhibitors of dipeptidyl peptidase iv
|
|
US6727261B2
(en)
|
2001-12-27 |
2004-04-27 |
Hoffman-La Roche Inc. |
Pyrido[2,1-A]Isoquinoline derivatives
|
|
ATE352312T1
(de)
|
2001-12-29 |
2007-02-15 |
Novo Nordisk As |
Kombinierte verwendung einer glp-1-verbindung und eines aldose reduktase inhibitors
|
|
JP2005513165A
(ja)
|
2002-01-11 |
2005-05-12 |
ノボ ノルディスク アクティーゼルスカブ |
糖尿病、高血圧、慢性心不全および体液貯留状態の治療のための方法および組成物
|
|
EP1474139B1
(en)
|
2002-02-01 |
2007-11-21 |
Merck & Co., Inc. |
11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
|
|
US7101898B2
(en)
|
2002-02-01 |
2006-09-05 |
Novo Nordisk A/S |
Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
|
|
WO2003063903A2
(en)
|
2002-02-01 |
2003-08-07 |
Probiodrug Ag |
Modulation of t lymphocytes using dp iv inhibitors
|
|
RU2285693C2
(ru)
|
2002-02-13 |
2006-10-20 |
Ф.Хоффманн-Ля Рош Аг |
Производные пиридина и хинолина, способ их получения, фармацевтическая композиция, применение соединений для лечения заболеваний, ассоциированных с dpp-iv
|
|
CA2474578C
(en)
*
|
2002-02-13 |
2009-08-25 |
F. Hoffmann-La Roche Ag |
Novel pyridin- and pyrimidin-derivatives
|
|
AU2003248354A1
(en)
|
2002-02-27 |
2003-09-09 |
Pfizer Products Inc. |
Acc inhibitors
|
|
KR20040095241A
(ko)
|
2002-02-28 |
2004-11-12 |
프로시디온 리미티드 |
글루타미닐계 ｄｐｉｖ 억제제
|
|
HUP0200849A2
(hu)
|
2002-03-06 |
2004-08-30 |
Sanofi-Synthelabo |
N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
|
|
US20080070864A1
(en)
|
2002-03-07 |
2008-03-20 |
X-Ceptor Therapeutics, Inc. |
Quinazolinone Modulators Of Nuclear Receptors
|
|
US20050234129A1
(en)
|
2002-03-11 |
2005-10-20 |
Sutton Paul A |
Salts of nateglinide
|
|
PT1483247E
(pt)
|
2002-03-13 |
2009-08-18 |
Euro Celtique Sa |
Pirimidinas substituídas por arilo e a sua utilização
|
|
DE10211555A1
(de)
|
2002-03-15 |
2003-10-02 |
Imtm Inst Fuer Medizintechnolo |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit sebozytärer Hyperproliferation und veränderten Differenzierungszuständen
|
|
TW200305415A
(en)
|
2002-03-22 |
2003-11-01 |
Novartis Ag |
Combination of organic compounds
|
|
DE60316416T2
(de)
|
2002-03-25 |
2008-06-26 |
Merck & Co., Inc. |
Heterocyclische beta-aminoverbindungen als inhibitoren der dipeptidylpeptidase zur behandlung bzw. prävention von diabetes
|
|
JP4171702B2
(ja)
|
2002-03-25 |
2008-10-29 |
日本化薬株式会社 |
新規α−アミノ−Ｎ−（ジアミノホスフィニル）ラクタム誘導体
|
|
US20030232761A1
(en)
|
2002-03-28 |
2003-12-18 |
Hinke Simon A. |
Novel analogues of glucose-dependent insulinotropic polypeptide
|
|
PE20040079A1
(es)
|
2002-04-03 |
2004-04-19 |
Novartis Ag |
Derivados de indolilmaleimida
|
|
US20040106802A1
(en)
|
2002-04-08 |
2004-06-03 |
Torrent Pharmaceuticals Ltd. |
Novel compounds and therapeutic uses thereof
|
|
EP1492777A1
(en)
|
2002-04-08 |
2005-01-05 |
Torrent Pharmaceuticals Ltd |
Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors
|
|
AU2003228793B2
(en)
|
2002-04-30 |
2008-01-03 |
Trustees Of Tufts College |
Smart Pro-Drugs of Serine Protease Inhibitors
|
|
TW200307667A
(en)
*
|
2002-05-06 |
2003-12-16 |
Bristol Myers Squibb Co |
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
|
|
US7057046B2
(en)
*
|
2002-05-20 |
2006-06-06 |
Bristol-Myers Squibb Company |
Lactam glycogen phosphorylase inhibitors and method of use
|
|
TW200407143A
(en)
|
2002-05-21 |
2004-05-16 |
Bristol Myers Squibb Co |
Pyrrolotriazinone compounds and their use to treat diseases
|
|
US7034033B2
(en)
|
2002-05-23 |
2006-04-25 |
Chiron Corporation |
Substituted quinazolinone compounds
|
|
GB0212412D0
(en)
|
2002-05-29 |
2002-07-10 |
Novartis Ag |
Combination of organic compounds
|
|
US6710040B1
(en)
*
|
2002-06-04 |
2004-03-23 |
Pfizer Inc. |
Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors
|
|
AU2003233010A1
(en)
|
2002-06-04 |
2003-12-19 |
Pfizer Products Inc. |
Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
|
|
AU2003232405A1
(en)
|
2002-06-04 |
2003-12-19 |
Pfizer Products Inc. |
Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
|
|
CN100348599C
(zh)
|
2002-06-06 |
2007-11-14 |
卫材R&D管理有限公司 |
新的稠合咪唑衍生物
|
|
AR040241A1
(es)
|
2002-06-10 |
2005-03-23 |
Merck & Co Inc |
Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia
|
|
HUP0202001A2
(hu)
|
2002-06-14 |
2005-08-29 |
Sanofi-Aventis |
DDP-IV gátló hatású azabiciklooktán- és nonánszármazékok
|
|
MXPA04012860A
(es)
|
2002-06-17 |
2005-09-20 |
Smithkline Beecham Corp |
Proceso quimico.
|
|
WO2003106628A2
(en)
*
|
2002-06-17 |
2003-12-24 |
Bristol-Myers Squibb Company |
Benzodiazepine inhibitors of mitochondial f1f0 atp hydrolase and methods of inhibiting f1f0 atp hydrolase
|
|
SE0201976D0
(sv)
|
2002-06-24 |
2002-06-24 |
Astrazeneca Ab |
Novel compounds
|
|
US20040006004A1
(en)
|
2002-06-27 |
2004-01-08 |
Markku Koulu |
Method for prevention and treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
US20040054171A1
(en)
*
|
2002-07-04 |
2004-03-18 |
Jensen Anette Frost |
Polymorphic forms of a 4H-thieno[3,2-E]-1,2,4-thiadiazine 1,1-dioxide derivative
|
|
PL374860A1
(en)
|
2002-07-09 |
2005-11-14 |
Bristol-Myers Squibb Company |
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
|
|
AU2003265264A1
(en)
|
2002-07-09 |
2004-01-23 |
Point Therapeutics, Inc. |
Methods and compositions relating to isoleucine boroproline compounds
|
|
KR101120337B1
(ko)
|
2002-07-09 |
2012-02-29 |
브리스톨-마이어스 스큅 컴퍼니 |
항당뇨제 및 항비만제로서 유용한 치환된 헤테로시클릭유도체 및 방법
|
|
JPWO2004007446A1
(ja)
|
2002-07-10 |
2005-11-10 |
アステラス製薬株式会社 |
新規なアゼチジン誘導体又はその塩
|
|
JP4530852B2
(ja)
|
2002-07-15 |
2010-08-25 |
メルク・シャープ・エンド・ドーム・コーポレイション |
糖尿病治療のためのピペリジノピリミジンジペプチジルペプチダーゼ阻害剤
|
|
JP2004099600A
(ja)
|
2002-07-19 |
2004-04-02 |
Sankyo Co Ltd |
二環性アミノ基置換化合物を含有する医薬組成物
|
|
JP4153911B2
(ja)
|
2002-07-29 |
2008-09-24 |
田辺三菱製薬株式会社 |
ジペプチジルペプチダーゼｉｖの立体構造
|
|
ATE401311T1
(de)
|
2002-08-08 |
2008-08-15 |
Takeda Pharmaceutical |
Kondensierte heterozyklische verbindungen als petidase inhibitoren
|
|
DE60226517D1
(de)
|
2002-08-09 |
2008-06-19 |
Prosidion Ltd |
Dipeptidyl peptidase iv inhibitoren zur senkung der chronische gewichtszunahme
|
|
CA2496249C
(en)
|
2002-08-21 |
2012-01-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the production thereof and the use of the same as medicaments
|
|
US7407955B2
(en)
*
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
|
DE10238470A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7495005B2
(en)
|
2002-08-22 |
2009-02-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, their preparation and their use in pharmaceutical compositions
|
|
DE10238477A1
(de)
|
2002-08-22 |
2004-03-04 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Purinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7304166B2
(en)
|
2002-08-29 |
2007-12-04 |
Taisho Pharmaceutical Co., Ltd. |
Benzenesulfonate salt of 4-fluoro-2-cyanopyrrolidine derivatives
|
|
US6998502B1
(en)
|
2002-09-05 |
2006-02-14 |
Sabinsa Corporation |
Convenient process of manufacture for difluoromethylornithine and related compounds
|
|
EP1398032A1
(en)
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
EP1537880A4
(en)
|
2002-09-11 |
2009-07-01 |
Takeda Pharmaceutical |
PREPARATION FOR PROLONGED RELEASE
|
|
JP2004123738A
(ja)
|
2002-09-11 |
2004-04-22 |
Takeda Chem Ind Ltd |
徐放性製剤
|
|
US20040058876A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Torsten Hoffmann |
Secondary binding site of dipeptidyl peptidase IV (DP IV)
|
|
ATE461212T1
(de)
|
2002-09-18 |
2010-04-15 |
Prosidion Ltd |
Sekundäre bindungsstelle von dipeptidylpeptidase iv (dp iv)
|
|
US7262207B2
(en)
|
2002-09-19 |
2007-08-28 |
Abbott Laboratories |
Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
|
|
ATE368647T1
(de)
|
2002-09-19 |
2007-08-15 |
Abbott Lab |
Pharmazeutische zusammensetzung und ihre verwendung als inhibitoren von der dipeptidyl peptidase iv (dpp-iv)
|
|
MXPA05003252A
(es)
|
2002-09-26 |
2005-07-05 |
Eisai Co Ltd |
Farmaco de combinacion.
|
|
US6869966B2
(en)
|
2002-09-30 |
2005-03-22 |
Banyu Pharmaceutical Co., Ltd. |
N-substituted-2-oxodihydropyridine derivatives
|
|
AU2003275404A1
(en)
|
2002-10-07 |
2004-05-04 |
Merck & Co., Inc. |
Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors
|
|
AU2003269850A1
(en)
|
2002-10-08 |
2004-05-04 |
Novo Nordisk A/S |
Hemisuccinate salts of heterocyclic dpp-iv inhibitors
|
|
AU2003282510A1
(en)
|
2002-10-11 |
2004-05-04 |
Bristol-Myers Squibb Company |
Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
|
|
WO2004037169A2
(en)
|
2002-10-18 |
2004-05-06 |
Merck & Co., Inc. |
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
EP1553947A4
(en)
|
2002-10-21 |
2006-11-29 |
Bristol Myers Squibb Co |
QUINAZOLINONES AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
|
|
EP1553937B1
(en)
|
2002-10-23 |
2010-06-02 |
Bristol-Myers Squibb Company |
Glycinenitrile-based inhibitors of dipeptidyl peptidase iv
|
|
WO2004041795A1
(en)
|
2002-10-30 |
2004-05-21 |
Guilford Pharmaceuticals Inc. |
Novel inhibitors of dipeptidyl peptidase iv
|
|
ES2278213T3
(es)
|
2002-11-07 |
2007-08-01 |
MERCK & CO., INC. |
Derivados de fenilamina como inhibidores de la dipeptidilpeptidasa en el tratamiento o la prevencion de la diabetes.
|
|
US7482337B2
(en)
|
2002-11-08 |
2009-01-27 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
CA2502068A1
(en)
|
2002-11-18 |
2004-06-03 |
Pfizer Products Inc. |
Dipeptidyl peptidase iv inhibiting fluorinated cyclic amides
|
|
DE10254304A1
(de)
|
2002-11-21 |
2004-06-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
AU2002952946A0
(en)
|
2002-11-27 |
2002-12-12 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
US7109192B2
(en)
*
|
2002-12-03 |
2006-09-19 |
Boehringer Ingelheim Pharma Gmbh & Co Kg |
Substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
|
|
UY28103A1
(es)
|
2002-12-03 |
2004-06-30 |
Boehringer Ingelheim Pharma |
Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos
|
|
DE10256264A1
(de)
|
2002-12-03 |
2004-06-24 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue substituierte Imidazo-pyridinone und Imidazo-pyridazinone, ihre Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1578414A4
(en)
|
2002-12-04 |
2007-10-24 |
Merck & Co Inc |
PHENYLALANINE DERIVATIVES ALSDIPEPTIDYL-PEPTIDASE INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
|
|
RU2328498C9
(ru)
|
2002-12-04 |
2008-12-10 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Соединения с конденсированным 1,3-дигидроимидазольным циклом
|
|
US7420079B2
(en)
|
2002-12-09 |
2008-09-02 |
Bristol-Myers Squibb Company |
Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
|
|
CA2508947A1
(en)
|
2002-12-20 |
2004-07-15 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
US7135467B2
(en)
|
2003-01-13 |
2006-11-14 |
Bristol-Myers Squibb Company |
HIV integrase inhibitors
|
|
AU2004206812A1
(en)
|
2003-01-17 |
2004-08-05 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
CA2514191C
(en)
|
2003-01-31 |
2011-10-11 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Compound inhibiting dipeptidyl peptidase iv
|
|
WO2004069162A2
(en)
|
2003-01-31 |
2004-08-19 |
Merck & Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
WO2004071454A2
(en)
|
2003-02-13 |
2004-08-26 |
Guilford Pharmaceuticals Inc. |
Substituted azetidine compounds as inhibitors of dipeptidyl peptidase iv
|
|
DE10308351A1
(de)
|
2003-02-27 |
2004-11-25 |
Aventis Pharma Deutschland Gmbh |
1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
DE10308353A1
(de)
|
2003-02-27 |
2004-12-02 |
Aventis Pharma Deutschland Gmbh |
Diarylcycloalkylderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US7148246B2
(en)
|
2003-02-27 |
2006-12-12 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
|
|
DE10308356A1
(de)
|
2003-02-27 |
2004-09-09 |
Aventis Pharma Deutschland Gmbh |
Cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
|
AU2003207881A1
(en)
|
2003-02-28 |
2004-09-17 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
WO2004076434A1
(en)
|
2003-02-28 |
2004-09-10 |
Aic |
Dipeptidyl peptidase inhibitors
|
|
WO2004078777A2
(en)
|
2003-03-04 |
2004-09-16 |
Biorexis Pharmaceutical Corporation |
Dipeptidyl-peptidase protected proteins
|
|
AR043443A1
(es)
|
2003-03-07 |
2005-07-27 |
Merck & Co Inc |
Procedimiento de preparacion de tetrahidrotriazolopirazinas y productos intermedios
|
|
US20050014732A1
(en)
*
|
2003-03-14 |
2005-01-20 |
Pharmacia Corporation |
Combination of an aldosterone receptor antagonist and an anti-diabetic agent
|
|
AR043505A1
(es)
|
2003-03-18 |
2005-08-03 |
Merck & Co Inc |
Preparacion de beta-cetoamidas e intermediarios de reaccion
|
|
WO2004085661A2
(en)
|
2003-03-24 |
2004-10-07 |
Merck & Co., Inc |
Process to chiral beta-amino acid derivatives
|
|
EP1608317B1
(en)
|
2003-03-25 |
2012-09-26 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
TWI357408B
(en)
|
2003-03-26 |
2012-02-01 |
Mitsubishi Tanabe Pharma Corp |
3-substituted-4-pyrimidone derivatives
|
|
EP1613318A4
(en)
|
2003-03-26 |
2009-03-11 |
Bayer Pharmaceuticals Corp |
COMPOUNDS AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISEASES
|
|
WO2004087650A2
(en)
|
2003-03-27 |
2004-10-14 |
Merck & Co. Inc. |
Process and intermediates for the preparation of beta-amino acid amide dipeptidyl peptidase-iv inhibitors
|
|
WO2004089362A1
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
2-cyanopyrroles and their analogues as ddp-iv inhibitors
|
|
WO2004096806A1
(ja)
|
2003-04-30 |
2004-11-11 |
Sumitomo Pharmaceuticals Co. Ltd. |
縮合イミダゾール誘導体
|
|
AU2004237408C9
(en)
|
2003-05-05 |
2010-04-15 |
Probiodrug Ag |
Medical use of inhibitors of glutaminyl and glutamate cyclases
|
|
WO2004099134A2
(en)
|
2003-05-05 |
2004-11-18 |
Prosidion Ltd. |
Glutaminyl based dp iv-inhibitors
|
|
PT1620082E
(pt)
*
|
2003-05-05 |
2010-06-11 |
Probiodrug Ag |
Utilização médica de inibidores de ciclases de glutaminilo e glutamato para o tratamento da doença de alzheimer e síndrome de down
|
|
EP1620091B1
(en)
|
2003-05-05 |
2010-03-31 |
Probiodrug AG |
Inhibitors of glutaminyl cyclase
|
|
AU2003902260A0
(en)
|
2003-05-09 |
2003-05-29 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
CA2524531A1
(en)
|
2003-05-14 |
2004-12-02 |
Merck And Co., Inc. |
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
JP2007511467A
(ja)
|
2003-05-14 |
2007-05-10 |
タケダ サン ディエゴ インコーポレイテッド |
ジペプチジルペプチダーゼインヒビター
|
|
WO2004101514A1
(ja)
|
2003-05-15 |
2004-11-25 |
Taisho Pharmaceutical Co., Ltd. |
シアノフルオロピロリジン誘導体
|
|
EP1631680A2
(en)
|
2003-05-21 |
2006-03-08 |
Bayer HealthCare AG |
Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4)
|
|
WO2004104215A2
(en)
|
2003-05-21 |
2004-12-02 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase 7 (dpp7)
|
|
CN1798556A
(zh)
|
2003-06-06 |
2006-07-05 |
麦克公司 |
作为治疗或者预防糖尿病的二肽基肽酶抑制剂的稠合吲哚
|
|
AU2003902946A0
(en)
|
2003-06-12 |
2003-06-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Dpp-iv inhibitor
|
|
CA2527806A1
(en)
|
2003-06-17 |
2004-12-29 |
Merck & Co., Inc. |
Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
|
|
DE10327439A1
(de)
|
2003-06-18 |
2005-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Imidazopyridazinon- und Imidazopyridonderivate, deren Herstellung und deren Verwendung als Arzneimittel
|
|
US7566707B2
(en)
*
|
2003-06-18 |
2009-07-28 |
Boehringer Ingelheim International Gmbh |
Imidazopyridazinone and imidazopyridone derivatives, the preparation thereof and their use as pharmaceutical compositions
|
|
RS52397B
(sr)
|
2003-06-20 |
2013-02-28 |
F.Hoffmann-La Roche Ag |
Derivati pirido /2,1-a/izohinolina kao dpp-iv inhibitori
|
|
KR100744893B1
(ko)
|
2003-06-20 |
2007-08-01 |
에프. 호프만-라 로슈 아게 |
Ｄｐｐ-ｉｖ 저해제로서 헥사하이드로피리도아이소퀴놀린
|
|
JO2625B1
(en)
|
2003-06-24 |
2011-11-01 |
ميرك شارب اند دوم كوربوريشن |
Phosphoric acid salts of dipeptidyl betidase inhibitor 4
|
|
DE10330842A1
(de)
|
2003-07-08 |
2005-02-10 |
Institut für Medizintechnologie Magdeburg GmbH, IMTM |
Verwendung der Inhibitoren von Enzymen mit Aktivitäten der Aminopeptidase N und/oder der Dipeptidylpeptidase IV und pharmazeutischen Zubereitungen daraus zur Therapie und Prävention dermatologischer Erkrankungen mit Hyperproliferation und veränderten Differenzierungszuständen von Fibroblasten
|
|
WO2005011581A2
(en)
|
2003-07-31 |
2005-02-10 |
Merck & Co., Inc. |
Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
US6995183B2
(en)
*
|
2003-08-01 |
2006-02-07 |
Bristol Myers Squibb Company |
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
US7579357B2
(en)
|
2003-08-13 |
2009-08-25 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
WO2005019168A2
(en)
*
|
2003-08-20 |
2005-03-03 |
Pfizer Products Inc. |
Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
|
|
WO2005030751A2
(en)
|
2003-09-08 |
2005-04-07 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
|
JP2007505121A
(ja)
|
2003-09-08 |
2007-03-08 |
武田薬品工業株式会社 |
ジペプチジルぺプチダーゼ阻害剤
|
|
JP4996926B2
(ja)
|
2004-02-05 |
2012-08-08 |
プロビオドルグ エージー |
グルタミニルシクラーゼの新規の阻害剤
|
|
CN102127057A
(zh)
*
|
2004-03-15 |
2011-07-20 |
武田药品工业株式会社 |
二肽基肽酶抑制剂
|
|
NZ552984A
(en)
|
2004-07-02 |
2010-06-25 |
Corcept Therapeutics Inc |
Modified pyrimidine glucocorticoid receptor modulators
|
|
JP2008524331A
(ja)
|
2004-12-21 |
2008-07-10 |
武田薬品工業株式会社 |
ジペプチジルペプチダーゼ阻害剤
|
|
ZA200802857B
(en)
|
2005-09-14 |
2009-09-30 |
Takeda Pharmaceutical |
Dipeptidyl peptidase inhibitors for treating diabetes
|
|
PE20070622A1
(es)
|
2005-09-14 |
2007-08-22 |
Takeda Pharmaceutical |
Administracion de inhibidores de dipeptidil peptidasa
|
|
WO2007033266A2
(en)
|
2005-09-14 |
2007-03-22 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors for treating diabetis
|
|
TW200745079A
(en)
|
2005-09-16 |
2007-12-16 |
Takeda Pharmaceuticals Co |
Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
|